|
Jul 1
|
Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
|
|
Jun 10
|
Eli Lilly Bets $870 Million on Extended-Release Obesity Drugs
|
|
Feb 14
|
Camurus AB (FRA:7CA) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansion
|